Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
46 Results Found
Member Call: CMS RFI on Health Equity - May 11, 2021
Member Call: CMS RFI on Health Equity - May 11, 2021
Member Call: Post-acute Care Update, April 13, 2021
Resources from the Post-Acute Care member call, April 27, 2021.
Member Call: Long Term Care Hospital PPS FY 2022 Proposed Rule, May 19, 2021
Resources from the Long Term Care Hospital PPS FY 2022 Proposed Rule member call, May 19, 2021.
Member Call: Hospice and Home Health Challenges with Medicare Advantage March 30, 2021
Resources from the Hospice and Home Health Challenges with Medicare Advantage member call, March 30, 2021.
ASHHRA Exchange LIVE - Access Info
Engage in dialogue in real-time dialogue with your fellow ASHHRA members on specific topics relevant to you and the health care HR field. This monthly event is a unique opportunity for you to ask questions, raise issues and share your ideas with immediate feedback from fellow ASHHRA members.
Log in to the ASHHRA website and access the registration link.
Inpatient Rehabilitation Facility PPS: Proposed Rule FY2021 Call, May 20, 2020
Listen to call audio here.
Member Call: LTCH PPS: Proposed Rule FY 2021, June 10, 2020
Resources from the LTCH PPS: Proposed Rule FY 2021 member call held June 10, 2020. Listen to the call below. View the presentation slides and Regulatory Advisory under key resources.
Home Health Final Rule Call, FY 2021, November 19, 2020
Resources from the Home Health Final Rule FY 2021 Call, held November 19, 2020. Listen to the call below. View the presentation slides and Regulatory Advisory under key resources.
Allocation and Distribution of OWS Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR
An AHA Member Call on Allocation and Distribution of Operation Warp Speed (OWS) Therapeutics with Nancy Foster and John Redd, MD, CMO, ASPR, including remdesivir and monoclonal antibody (MAB) therapeutics like bamlanivimab through the Emergency Use Authorization (EUA).